ALKS
Price
$26.13
Change
-$0.40 (-1.51%)
Updated
Jul 25 closing price
Capitalization
4.55B
2 days until earnings call
INDV
Price
$17.14
Change
+$0.33 (+1.96%)
Updated
Jul 25 closing price
Capitalization
2.91B
4 days until earnings call
Interact to see
Advertisement

ALKS vs INDV

Header iconALKS vs INDV Comparison
Open Charts ALKS vs INDVBanner chart's image
Alkermes
Price$26.13
Change-$0.40 (-1.51%)
Volume$1.69M
Capitalization4.55B
Indivior
Price$17.14
Change+$0.33 (+1.96%)
Volume$5.04M
Capitalization2.91B
ALKS vs INDV Comparison Chart in %
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. INDV commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and INDV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ALKS: $26.13 vs. INDV: $17.14)
Brand notoriety: ALKS and INDV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 96% vs. INDV: 262%
Market capitalization -- ALKS: $4.55B vs. INDV: $2.91B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. INDV’s [@Pharmaceuticals: Other] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 0 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • ALKS’s FA Score: 0 green, 5 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, ALKS is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while INDV’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 7 bearish.
  • INDV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INDV is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а -10.57% price change this week, while INDV (@Pharmaceuticals: Other) price change was +7.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.53%. For the same industry, the average monthly price growth was +11.98%, and the average quarterly price growth was +75.52%.

Reported Earning Dates

ALKS is expected to report earnings on Oct 22, 2025.

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than INDV($2.91B). INDV has higher P/E ratio than ALKS: INDV (2102.00) vs ALKS (8.90). INDV YTD gains are higher at: 37.892 vs. ALKS (-9.145). ALKS has higher annual earnings (EBITDA): 519M vs. INDV (66M). ALKS has more cash in the bank: 773M vs. INDV (410M). INDV has less debt than ALKS: INDV (282M) vs ALKS (372M). ALKS has higher revenues than INDV: ALKS (1.66B) vs INDV (1.09B).
ALKSINDVALKS / INDV
Capitalization4.55B2.91B157%
EBITDA519M66M786%
Gain YTD-9.14537.892-24%
P/E Ratio8.902102.000%
Revenue1.66B1.09B152%
Total Cash773M410M189%
Total Debt372M282M132%
FUNDAMENTALS RATINGS
ALKS vs INDV: Fundamental Ratings
ALKS
INDV
OUTLOOK RATING
1..100
5744
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
4957
SMR RATING
1..100
3861
PRICE GROWTH RATING
1..100
8138
P/E GROWTH RATING
1..100
5399
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALKS's Valuation (99) in the Biotechnology industry is in the same range as INDV (100) in the null industry. This means that ALKS’s stock grew similarly to INDV’s over the last 12 months.

ALKS's Profit vs Risk Rating (49) in the Biotechnology industry is in the same range as INDV (57) in the null industry. This means that ALKS’s stock grew similarly to INDV’s over the last 12 months.

ALKS's SMR Rating (38) in the Biotechnology industry is in the same range as INDV (61) in the null industry. This means that ALKS’s stock grew similarly to INDV’s over the last 12 months.

INDV's Price Growth Rating (38) in the null industry is somewhat better than the same rating for ALKS (81) in the Biotechnology industry. This means that INDV’s stock grew somewhat faster than ALKS’s over the last 12 months.

ALKS's P/E Growth Rating (53) in the Biotechnology industry is somewhat better than the same rating for INDV (99) in the null industry. This means that ALKS’s stock grew somewhat faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSINDV
RSI
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 18 days ago
75%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
72%
Aroon
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSLIX42.170.39
+0.93%
Hartford Small Cap Growth I
PTSGX18.610.12
+0.65%
Touchstone Sands Capital Select Growth Z
FREAX14.57-0.02
-0.14%
Nuveen Real Estate Securities A
VEILX15.34-0.03
-0.20%
VELA International A
RIIEX43.31-0.18
-0.41%
American Funds Intl Gr and Inc R2E

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with COLL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then COLL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-1.51%
COLL - ALKS
35%
Loosely correlated
-1.03%
ESPR - ALKS
34%
Loosely correlated
+1.34%
AMRX - ALKS
34%
Loosely correlated
+0.75%
PRGO - ALKS
34%
Loosely correlated
+1.14%
VTRS - ALKS
33%
Loosely correlated
+0.64%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+1.96%
CAIHF - INDV
27%
Poorly correlated
N/A
COLL - INDV
27%
Poorly correlated
-1.03%
ASRT - INDV
26%
Poorly correlated
-1.27%
ALKS - INDV
24%
Poorly correlated
-1.51%
MKKGY - INDV
24%
Poorly correlated
-0.52%
More